Edition:
United States

Alnylam Pharmaceuticals Inc (ALNY.O)

ALNY.O on Nasdaq

38.51USD
18 Jan 2017
Change (% chg)

$0.29 (+0.76%)
Prev Close
$38.22
Open
$39.04
Day's High
$39.04
Day's Low
$37.02
Volume
1,187,252
Avg. Vol
1,512,299
52-wk High
$80.19
52-wk Low
$31.38

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -1.33 December 18 Jan 2017

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 1 2 2
(2) OUTPERFORM 6 6 6 6
(3) HOLD 7 7 7 7
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.43 2.43 2.33 2.33

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Mar-17 3 7.08 10.50 3.75 --
Quarter Ending Jun-17 3 7.25 11.00 3.75 --
Year Ending Dec-17 15 48.98 123.00 9.00 113.27
Earnings (per share)
Quarter Ending Mar-17 3 -1.33 -1.18 -1.41 --
Quarter Ending Jun-17 3 -1.37 -1.20 -1.51 --
Year Ending Dec-17 13 -5.05 -4.16 -6.15 -3.23

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-16 9.14 13.65 4.51 49.35
Quarter Ending Jun-16 8.09 8.71 0.62 7.64
Quarter Ending Mar-16 7.74 7.34 0.40 5.16
Quarter Ending Dec-15 9.10 7.55 1.55 17.00
Quarter Ending Sep-15 7.55 6.32 1.22 16.22
Earnings (per share)
Quarter Ending Sep-16 -1.14 -1.21 0.07 -6.35
Quarter Ending Jun-16 -1.24 -1.05 0.19 -15.38
Quarter Ending Mar-16 -1.05 -1.21 0.16 -15.13
Quarter Ending Dec-15 -0.96 -1.07 0.11 -11.96
Quarter Ending Sep-15 -0.91 -0.91 0.00 -0.46

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Mar-17 7.08 7.08 7.08 7.08 --
Quarter Ending Jun-17 7.25 7.25 7.25 7.25 --
Year Ending Dec-17 48.98 48.98 51.23 55.17 113.27
Earnings (per share)
Quarter Ending Mar-17 -1.33 -1.33 -1.33 -1.33 --
Quarter Ending Jun-17 -1.37 -1.37 -1.37 -1.37 --
Year Ending Dec-17 -5.05 -5.05 -5.16 -5.12 -3.23

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Mar-17 0 0 0 0
Quarter Ending Jun-17 0 0 0 0
Year Ending Dec-17 0 0 1 1
Earnings
Quarter Ending Mar-17 0 0 0 0
Quarter Ending Jun-17 0 0 0 0
Year Ending Dec-17 0 0 2 0